JUN 10, 2021 8:10 AM PDT

The PrecivityAD™ Blood Test: A Precise, Robust LC-MS/MS Method to Identify Brain Amyloid Pathology in Patients with Mild Cognitive Impairment

Speaker

Abstract

The World Alzheimer's Report estimates that ~50M people live with dementia, of which Alzheimer's disease (AD) represents approximately 60-80% of all cases. Early diagnosis is imperative for early treatment and prevention, which offer the greatest chances for changing the future trajectory of AD. An urgent medical need exists for accurate, simple, lower-cost, radiation-free, and widely accessible blood-based tests to improve the diagnostic evaluation of patients with memory impairment and at risk for AD. A blood-based test (PrecivityAD™) was introduced into the clinic in 2020 as a CLIA-certified laboratory developed test performed by C2N Diagnostics. The test relies on LC-MS/MS to measure in plasma amyloid beta (Aβ) protein isoforms Aβ42 and Aβ40 and detect the presence of Apolipoprotein E (ApoE)-specific peptides. The data strongly support the test's role as a clinically useful tool to identify brain amyloid pathology, as well as its role in aiding the AD diagnostic evaluation process among individuals presenting to their clinicians with cognitive impairment.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
DEC 07, 2021 10:00 AM PST
C.E. CREDITS
DEC 07, 2021 10:00 AM PST
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds